Cargando…
Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future
Advanced gastrointestinal (GI) malignancies are varied in presentation, prognosis, and treatment options. With the exception of resectable recurrent colorectal cancer, metastatic GI malignancies are incurable. Cytotoxic chemotherapies have been the mainstay of therapy for decades but limited extensi...
Autores principales: | Mulder, Karen, Koski, Sheryl, Scarfe, Andrew, Chu, Quincy, King, Karen, Spratlin, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248127/ https://www.ncbi.nlm.nih.gov/pubmed/21317448 |
Ejemplares similares
-
Looking to the Future: Biomarkers in the Management of Pancreatic Adenocarcinoma
por: Spratlin, Jennifer L., et al.
Publicado: (2011) -
The development of antimicrobial agents, past, present and future
Publicado: (2005) -
Past, Present, and Future of Gastrointestinal Microbiota Research in Cats
por: Lyu, Yang, et al.
Publicado: (2020) -
Immunotherapy in hematologic malignancies: past, present, and future
por: Im, Annie, et al.
Publicado: (2017) -
Immunotherapy combined with antiangiogenic agents in patients with advanced malignant pleural mesothelioma: A case report
por: Xuan, Tian-Tian, et al.
Publicado: (2022)